CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Allan Musinguzi

ORCID: 0000-0001-9941-6433↗

Public evidence

1 connected articles

Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.2024 · medRxiv

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 08/09/2026.

Allan Musinguzi - Medical Cannabis Research Engine